Navigation Links
Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab

imumab. The primary endpoint of the study was to investigate the safety and clinical activity of various doses of ipilimumab. The study enrolled 88 patients with unresectable stage III or stage IV malignant melanoma in three cohorts receiving varying doses and regimens. Analysis of the data demonstrated:

    - Overall disease control - defined as objective responses (complete and

      partial) and stable disease - achieved in 19% (17/88) of patients.

      - In the cohort of 23 patients who were treated at 10 mg/kg, disease

        control was achieved in 39% (9/23), which lasted six months or longer

        in nearly all patients (8/9).

    - Duration of disease stabilization or response exceeded six months in 15%

      (13/88) of patients.  The longest effect observed (stable disease) is

      ongoing for more than a year.

Adverse events reported in this study were consistent with those immune- related adverse events (irAEs) results in other clinical trials of ipilimumab (diarrhea, rash, adrenal insufficiency, elevated liver enzymes). In this study, the overall incidence of irAEs was 72% (63/88). All patients who achieved a response (complete or partial responses) and most patients who achieved stable disease (12/13) also reported an irAE - primarily grade 1 or 2 with the exception of grade 3 diarrhea (1/88), adrenal insufficiency (1/88) and liver abnormalities (1/88) in three patients with stable disease. Twenty- eight percent (25/88) of patients reported serious adverse events (SAEs) regardless of causality, nine of which were ipilimumab-related, but not dose dependent. Most events were reversible without sequelae.

(Abstract #8525) Analysis of data aggregated from six Phase I and II trials, presented by Omid Hamid, MD, an investigator at The Angeles Clinic and Research Institute in Los Angeles, California, showed durable objective responses and stable disease in some patients who received varying doses of ipilimumab (0.1 up to
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
2. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
3. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
6. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
7. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
8. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine
9. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
Post Your Comments:
(Date:9/30/2014)... 2014   Acutus Medical, Inc. (ACM), ... 3D Cardiac Chamber Imaging and Dipole Density Mapping system ... sustain complex cardiac arrhythmias, including atrial fibrillation, announced it ... its imaging/mapping system as well as bring to market ... Medical to complete work on the AcQMap TM ...
(Date:9/30/2014)... , Sept. 30, 2014 One week after ... major milestone: Alzheimer,s Team reaches over 200,000 ... and caregivers, was developed to draw attention to clinical ... disease. It also provides inspirational support and fosters online ... as the leading healthcare concern for people over the ...
(Date:9/30/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... a finalist in the Diagnostics & Research Tools ... Awards, sponsored by CONNECT. CONNECT, a regional program that ... sciences products in San Diego County ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 2MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 4Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3
... SPRING, Md., June 24, 2011 Breast cancer patients and ... 7:00 am outside of the Federal Drug Administration (FDA).  At ... anti-cancer drug Avastin from the approved medication list for treatment ... in 2008 for use to treat breast cancer. ...
...   - Dossier Re-Examination ... a leader in,the field of human gene therapy, ... its Marketing Authorisation Application,(MAA) for Glybera® (alipogene tiparvovec) ... Following a recent,meeting with the European Medicines Agency,s ...
Cached Medicine Technology:Breast Cancer Patients and Families Stand Up To FDA 2Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 2Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 3Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 4
(Date:9/30/2014)... 30, 2014 ADOAMNI, Inc. ... campaign through GoFundMe. The campaign, which surpassed its goal ... portion of the funds necessary to convert a diesel ... Stockton Unified School District (SUSD). The campaign rallied citizens ... portion of the funds necessary for the conversion of ...
(Date:9/30/2014)... 2014 The American Parkinson ... funding supporting seven Research grants to junior investigators ... to support post-doctoral scientists whose research training holds ... etiology and treatment of Parkinson’s disease, and eight ... and medical centers across the country intended to ...
(Date:9/30/2014)... With accolades like the Most Inspirational Lash Artist ... Brand of My Brand Lashes is a leader of lash ... the ability to teach. She leads with a passion for ... reputation. , With a background in Cosmetology that spans 11 ... and as an Instructor. She has operated two of her ...
(Date:9/30/2014)... Got grapes? UCLA researchers have demonstrated how resveratrol, an ... to inhibit growth of the bacteria that causes acne. ... a common acne medication, benzoyl peroxide, may enhance the ... into new treatments. , Published in the current online ... the early lab findings demonstrated that resveratrol and benzoyl ...
(Date:9/30/2014)... -- MIT engineers have devised a way to rapidly ... making it easier to discover promising new ways to ... antibodies, peptides, RNA, and DNA, to human patients. , ... Biology , the researchers used this technology to identify ... also to rodents. This type of high-speed screen could ...
Breaking Medicine News(10 mins):Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 2Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 3Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 2Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 3Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 4Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 2Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 3Health News:Antioxidant found in grapes uncorks new targets for acne treatment 2Health News:Antioxidant found in grapes uncorks new targets for acne treatment 3Health News:High-speed drug screen 2Health News:High-speed drug screen 3
... (NP) is pleased to share today the release of Mr. Umar ... the Mindanao region of the Philippines who was kidnapped from the ... 13. Jaleel is alive and is currently en route to ... the vicinity of Tipo Tipo on Basilan. Jaleel was released ...
... , ... final program for Biopolymers Symposium 2009 taking place September 28 - 30th in Chicago, ... ... -- IntertechPira is pleased to announce the Biopolymers Symposium 2009 conference and exhibit, taking ...
... A. Magana awarded $25,000 each for leadership in increasing diversity ... 3 Guillermo J. Camacho, a dentist in West Covina, ... at California State Polytechnic University, Pomona, that encourages students of ... founded and directs a program at Cabrillo College ...
... if you,re a woman trying to figure out how to please her ... the gift you really want for yourself. , , (Photo: ... that probably rules out the ,65 Mustang and the even-bigger screen TV. ... for millions of women - one that would actually be a true ...
... for early confirmation of bile duct, pancreatic cancers, , WEDNESDAY, ... have developed new tests that make it easier to diagnose ... study, the new tests more than doubled the detection rate ... are not discovered until their later stages. , "The earlier ...
... , Health insurer chooses Cincom Eloquence to streamline policy ... software provider Cincom Systems announces that Medica ( ... to more than 1.5 million members, has chosen Cincom ... document automation processes. , , Key considerations for ...
Cached Medicine News:Health News:Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 2Health News:Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 3Health News:Biopolymers Symposium 2009 Announces Final Program and Interactive Green Brochure 2Health News:Mentors Who Support Students Receive TCWF Champions of Health Professions Diversity Award 2Health News:Mentors Who Support Students Receive TCWF Champions of Health Professions Diversity Award 3Health News:Perfect Father's Day Gift: The Sound of Silence 2Health News:Perfect Father's Day Gift: The Sound of Silence 3Health News:New Tests Spot Tough-to-Detect Cancers Sooner 2Health News:Medica Selects Cincom's Document Automation Software 2Health News:Medica Selects Cincom's Document Automation Software 3
...
... The Slim-LOC Plate is a ... intervertebral body fixation. The Slim-LOC is ... design, modified by current market technology. ... versatility & integrated instrumentation. Reduced width ...
... Osmium is a cervical plate system ... spine. The implant provides for the ... the bone transplant has consolidated. Optimized ... and bicortical fixation. Maximum purchase also ...
... meet the clinical challenges of anterior cervical ... and the choice of fixed angle screws ... for ease of implantation in complex cases. ... the surgeon the versatility of creating a ...
Medicine Products: